Senores Pharmaceuticals will restrict trading for insiders during financial results announcement per Back

<p>Senores Pharmaceuticals Limited will close its trading window for directors, promoters, designated persons, and their immediate relatives from October 1, 2026, until 48 hours after the announcement of the company’s unaudited financial results for the quarter and half-year ending September 30, 2026, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.</p>